findmyKOL
Clinical trialNCT01092767CompletedInterventional

Study to Determine if the Valiant Stent Graft is Safe and Effective in Treating Patients Who Have a Blunt Thoracic Aortic Injury

SponsorMedtronic CardiovascularEnrollment50Blunt Thoracic Aortic Injury
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine if the Valiant stent graft is safe and effective in treating patients who have a blunt thoracic aortic injury (BTAI). BTAI is when the aorta has been injured due to traumatic force to the chest area. It is commonly caused by motor vehicle accidents. In most cases it is life threatening and the standard treatment is surgery. Many times when a person has a BTAI they also have other injuries that can affect the results of the surgery. Since stent grafting has been an effective way to treat other aortic conditions such as aneurysms (bulge in aorta wall), it is believed that the Valiant stent graft would be effective in treating BTAI. A stent graft is a woven polyester tube (graft) supported by a metal frame of strong but flexible nitinol (type of metal) springs (stent) that is placed in the aorta to help seal the injury and keep it from bleeding.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • London Health Sciences Center

    London, Ontario, Canada

  • Laval Hospital

    Québec, Canada

United States
  • University of Alabama

    Birmingham, Alabama, United States

  • Cedars Sinai Medical Center

    Los Angeles, California, United States

  • Harbor Ucla

    Torrance, California, United States

  • Denver Health

    Denver, Colorado, United States

  • Yale New Haven Hospital

    New Haven, Connecticut, United States

  • University of Florida Shands Hospital

    Gainesville, Florida, United States

  • University of Miami Jackson Memorial

    Miami, Florida, United States

  • Bayfront Medical Center

    St. Petersburg, Florida, United States

  • Maine Medical Center

    Portland, Maine, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • William Beaumont Hospital

    Royal Oak, Michigan, United States

  • Cooper Health

    Camden, New Jersey, United States

  • Vascular Research Institute

    Morristown, New Jersey, United States

  • Duke University Medical Center

    Durham, North Carolina, United States

  • Toledo Hospital / Jobst Vascular Center

    Toledo, Ohio, United States

  • Ut Southwestern

    Dallas, Texas, United States

  • Memorial Hermann Heart and Vascular Institute

    Houston, Texas, United States

  • Brooke Army Medical Center

    San Antonio, Texas, United States

  • Scott and White Memorial

    Temple, Texas, United States

  • University of Virginia

    Charlottesville, Virginia, United States

  • Sentara Norfolk General Vascular & Transplant Specialists

    Norfolk, Virginia, United States

  • Medical College of Wisconsin Froedtert Hospital

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2010
Primary completion
30 Apr 2012
Completion
31 May 2017
Last update posted
29 Oct 2021
Registered enrollment
50
Registry id
NCT01092767

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.